Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04635059
Title Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer (BLAST)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

prostate adenocarcinoma

Therapies

Pacritinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.